Polyreactive autoantibodies in systemic lupus erythematosus have pathogenic potential

被引:63
|
作者
Zhang, Jie [1 ]
Jacobi, Annett M. [1 ]
Wang, Tao [1 ]
Berlin, RoseAnn [2 ]
Volpe, Bruce T. [2 ]
Diamond, Betty [1 ]
机构
[1] N Shore Long Isl Jewish Hlth Syst, Ctr Autoimmune & Musculoskeletal Dis, Feinstein Inst Med Res, Manhasset, NY 11030 USA
[2] Cornell Univ, Burke Cornell Med Res Inst, Weill Med Coll, Dept Neurol & Neurosci, White Plains, NY 10605 USA
关键词
Systemic lupus erythematosus; Autoantibodies; Ig class switching; Pathogenicity; ANTI-DNA ANTIBODIES; B-CELLS; IMPAIRMENT; PRECURSORS;
D O I
10.1016/j.jaut.2009.03.011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The present study was undertaken to deter-mine whether germline encoded and polyreactive antibodies might be pathogenic and whether the breach of early tolerance checkpoints in systemic lupus erythematosus (SLE) might lead to a population of B cells expressing germline encoded antibodies that become pathogenic merely by class switching to IgG in a pro-inflammatory milieu. We demonstrate here that IgM, DNA-reactive antibodies obtained from lupus patients that are unmutated and display polyreactivity can bind to isolated glomeruli and exhibit neurotoxic potential. Thus, the IgM polyreactive repertoire in SLE includes antibodies that may acquire pathogenic function merely by undergoing class-switch recombination to become IgG antibodies. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:270 / 274
页数:5
相关论文
共 50 条
  • [1] Autoantibodies in systemic lupus erythematosus
    Marks, Stephen D.
    Tullus, Kjell
    PEDIATRIC NEPHROLOGY, 2012, 27 (10) : 1855 - 1868
  • [2] Autoantibodies in systemic lupus erythematosus
    Stephen D. Marks
    Kjell Tullus
    Pediatric Nephrology, 2012, 27 : 1855 - 1868
  • [3] Viruses as potential pathogenic agents in systemic lupus erythematosus
    Nelson, P.
    Rylance, P.
    Roden, D.
    Trela, M.
    Tugnet, N.
    LUPUS, 2014, 23 (06) : 596 - 605
  • [4] Polyreactive antibodies in the circulation of patients with systemic lupus erythematosus
    Gunti, S.
    Kampylafka, E. I.
    Tzioufas, A. G.
    Notkins, A. L.
    LUPUS, 2015, 24 (14) : 1567 - 1569
  • [5] AUTOANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    MCCURDY, DK
    BICK, M
    GATTI, RA
    NAEIM, F
    DISEASE MARKERS, 1992, 10 (01) : 37 - 49
  • [6] AUTOANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    FARINAS, MC
    MEDICINA CLINICA, 1993, 100 (03): : 98 - 100
  • [7] Systemic lupus erythematosus, atherosclerosis, and autoantibodies
    Zampieri, S
    Iaccarino, L
    Ghirardello, A
    Tarricone, E
    Arienti, S
    Sarzi-Puttini, P
    Gambari, P
    Doria, A
    AUTOIMMUNE DISEASES AND TREATMENT: ORGAN-SPECIFIC AND SYSTEMIC DISORDERS, 2005, 1051 : 351 - 361
  • [8] An update on autoantibodies in systemic lupus erythematosus
    Gomez-Banuelos, Eduardo
    Fava, Andrea
    Andrade, Felipe
    CURRENT OPINION IN RHEUMATOLOGY, 2023, 35 (02) : 61 - 67
  • [9] Autoantibodies and glomerulonephritis in systemic lupus erythematosus
    Fu, SM
    Castillo, JD
    Deshmukh, US
    Lewis, JE
    Waters, ST
    Gaskin, F
    LUPUS, 2003, 12 (03) : 175 - 180
  • [10] Antinuclear autoantibodies in systemic lupus erythematosus
    Sawalha, AH
    Harley, JB
    CURRENT OPINION IN RHEUMATOLOGY, 2004, 16 (05) : 534 - 540